Research ArticleCancer

A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity

See allHide authors and affiliations

Science Translational Medicine  27 Jan 2021:
Vol. 13, Issue 578, eaba7308
DOI: 10.1126/scitranslmed.aba7308

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine